ArticleHematological oncology2018
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
Maria K Angelopoulou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleHematological oncology2018
Maria K Angelopoulou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.